Publications Plateforme de Biologie Cellulaire

  • 2018

Popovic B, Zannad F, Louis H, Clerc-Urmès I, Lakomy C, Gibot S, Denis CV, Lacolley P, Regnault V. Int J Cardiol. 2018 Jul 25. Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure.

  • 2017

Cointe S, Judicone C, Robert S, Mooberry MJ, Poncelet P, Wauben M, Nieuwland R, Key NS, Dignat-George F, Lacroix R. J Thromb Haemost. 2017 Jan;15(1):187-193. Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop.

Shaukat I, Barré L, Venkatesan N, Li D, Jaquinet JC, Fournel-Gigleux S, Ouzzine M. PLoS One. 2016 Jan 11;11(1):e0146499. Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-β1-Induced Fibrotic Phenotype in Lung Fibroblasts.

  • 2015

Ait Aissa K, Lagrange J, Mohamadi A, Louis H, Houppert B, Challande P, Wahl D, Lacolley P, Regnault V. Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):930-7. Vascular smooth muscle cells are responsible for a prothrombotic phenotype of spontaneously hypertensive rat arteries.

Reppel L, Schiavi J, Charif N, Leger L, Yu H, Pinzano A, Henrionnet C, Stoltz JF, Bensoussan D, Huselstein C. Stem Cell Res Ther. 2015 Dec 30;6:260. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton’s jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.

El Omar R, Xiong Y, Dostert G, Louis H, Gentils M, Menu P, Stoltz JF, Velot É, Decot V. Immunol Cell Biol. 2016 Apr;94(4):342-56. Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.

  • 2014

Reppel L, Margossian T, Yaghi L, Moreau P, Mercier N, Leger L, Hupont S, Stoltz JF, Bensoussan D, Huselstein C. Curr Stem Cell Res Ther. 2014;9(4):306-18. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton’s jelly: a critical parameter to consider in a therapeutic context.